The LSI Leadership Council is a group of biomedical industry leaders, venture capitalists and government officials. The council advises and supports the LSI leadership and faculty.

Members

  • Rajesh Alva, Managing Director, New Mountain Capital
  • Richard Douglas, Ph.D., Board of Directors, Novavax Inc.; Advisor, Red Sky Partners
  • James Flynn, Partner, Deerfield Management Company
  • David E. Kroin, Co-Founder and Managing Director, Great Point Partners LLC
  • Shiraz Ladiwala, Vice President, Strategy and Corporate Development, Thermo Fisher Scientific
  • Greg Margolies, Senior Partner and Head of Capital Markets Group, Ares Management LLC
  • Joel Martin, Ph.D., President and CEO, Dauntless Pharmaceuticals Inc.
  • Paul M. Meister, President, MacAndrews & Forbes Holdings Inc.; Co-Founder, Liberty Lane Partners LLC
  • Roger Newton, Ph.D., Founder, Executive Chairman and Chief Scientific Officer, Esperion Therapeutics
  • John E. Osborn, Executive in Residence, Warburg Pincus; Affiliate Professor, University of Washington, Seattle; Contributor, Forbes.com
  • Craig C. Parker, CEO, Surrozen
  • Liam Ratcliffe, M.D., Ph.D., General Partner, New Leaf Venture Partners LLC
  • Terry Rosen, Ph.D., CEO, Arcus Biosciences
  • Joseph Schwarz, M.D., Former U.S. Representative, 7th Congressional District, Michigan
  • Barry Sherman, M.D., Co-Founder, CEO and President, StemPar Sciences Inc.
  • Michael Staebler, Partner, Pepper Hamilton LLP
  • Burton Sutker, M.D., Radiologist, St. Clare’s Health System, New Jersey
  • David R. Walt, Ph.D., Core Faculty Member, Wyss Institute at Harvard University; Professor of Pathology, Harvard Medical School; Howard Hughes Medical Institute Professor; Founder of Illumina Inc. and Quanterix Corp.
  • Wendell Wierenga, Ph.D., Independent Consultant and former CEO and R&D leader in Biotech and Pharma